BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30118209)

  • 1. Characterization of SPR994, an Orally Available Carbapenem, with Activity Comparable to Intravenously Administered Carbapenems.
    Rubio A; Pucci MJ; Jain A
    ACS Infect Dis; 2018 Oct; 4(10):1436-1438. PubMed ID: 30118209
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Lacasse E; Brouillette E; Larose A; Parr TR; Rubio A; Malouin F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718255
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Cotroneo N; Rubio A; Critchley IA; Pillar C; Pucci MJ
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
    Eckburg PB; Muir L; Critchley IA; Walpole S; Kwak H; Phelan AM; Moore G; Jain A; Keutzer T; Dane A; Melnick D; Talley AK
    N Engl J Med; 2022 Apr; 386(14):1327-1338. PubMed ID: 35388666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084.
    Isoda T; Ushirogochi H; Satoh K; Takasaki T; Yamamura I; Sato C; Mihira A; Abe T; Tamai S; Yamamoto S; Kumagai T; Nagao Y
    J Antibiot (Tokyo); 2006 Apr; 59(4):241-7. PubMed ID: 16830892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.
    Ueda Y; Kanazawa K; Eguchi K; Takemoto K; Eriguchi Y; Sunagawa M
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4185-96. PubMed ID: 16189097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial activity of 2alpha-functionalized 1beta-methylcarbapenems related to KR-21012.
    Kwak HJ; Pyun DK; Kim JH; Kim EJ; Jeong HJ; Kim BJ; Lee CH
    Bioorg Med Chem Lett; 2000 Feb; 10(4):333-6. PubMed ID: 10714493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Tebipenem Hydrolysis by β-Lactamases Prevalent in Complicated Urinary Tract Infections.
    Sun Z; Su L; Cotroneo N; Critchley I; Pucci M; Jain A; Palzkill T
    Antimicrob Agents Chemother; 2022 May; 66(5):e0239621. PubMed ID: 35491852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects.
    Eckburg PB; Jain A; Walpole S; Moore G; Utley L; Manyak E; Dane A; Melnick D
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tebipenem, the first oral carbapenem antibiotic.
    Jain A; Utley L; Parr TR; Zabawa T; Pucci MJ
    Expert Rev Anti Infect Ther; 2018 Jul; 16(7):513-522. PubMed ID: 30014729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
    Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doripenem (Doribax)--a new parenteral carbapenem.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5-7. PubMed ID: 18219262
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel 1beta-methylcarbapenems having a new moiety at C-2.
    Kang YK; Shin KJ; Yoo KH; Seo KJ; Park SY; Kim DJ; Park SW
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2385-90. PubMed ID: 10476874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.
    McEntee L; Johnson A; Farrington N; Unsworth J; Dane A; Jain A; Cotroneo N; Critchley I; Melnick D; Parr T; Ambrose PG; Das S; Hope W
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral carbapenems.
    Shah PM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doripenem: a new addition to the carbapenem class of antimicrobials.
    Schafer JJ; Goff DA; Mangino JE
    Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):18-28. PubMed ID: 19149693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety.
    Kanno O; Miyauchi M; Shibayama T; Ohya S; Kawamoto I
    J Antibiot (Tokyo); 1999 Oct; 52(10):900-7. PubMed ID: 10604760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tebipenem pivoxil hydrobromide-No PICC, no problem!
    Sodhi V; Kronsberg KA; Clark M; Cho JC
    Pharmacotherapy; 2021 Sep; 41(9):748-761. PubMed ID: 34370326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.